key Try Dr. Verger's MODALITY CHOICE QUIZ. This quiz deals with issue of mortality with PD vs. HD, and patient factors tending to favor one modality choice over another. Other advantages versus disadvantages are explored, as well as what to do in a case where ultrafiltration failure threatens further PD treatment.

Mujais

Peritoneal dialysis adequacy: what is the role of ADEMEX?
Dr. Mujais presents the primary data from the ADEMEX trial and reviews how it was designed to answer questions raised while formulating the NKF-K/DOQI guidelines of peritoneal dialysis adequacy. What were the entry criteria? What were the doses and how were they delivered? What were the results and what implication does this have for PD adequacy guidelines in the future? (more...)

A17 Nabi completes patient enrollment for Phase III trial of StaphVax
J20 Lysophosphatidic acid may potentiate efficacy of antibiotics
J18 ASM conference on the New Phage Biology, August 1-5, Key Biscayne, FL
J13 Nabi ramping up manufacturing capacity of its Staph vaccine
J21 Vancomycin susceptibility in MRSA lineages (Emerging Infect Dis paper)
J21 MRSA (superbug) death rates set to double as vanco resistance grows
F11 JAMA: Patients more satisfied with PD than with HD in the first few months
N13 Peritoneal dialysis nurse resource guide from ANNA (PDF)
O31 Amino acid PD solution impairs forearm vasodilatation
O29 Blindness in children on PD reported; believed due to ischemic optic neuropathy
O29 Quebec company developing rapid, 1 hour screening test for MR Staph aureus
O19 Computer crime in the health care field: 2003 survey results
A22 CDC: VISA/VRSA (vancomycin- resistant Staph) testing algorithm
J16 Annals paper suggests that ramipril may help maintain GFR in PD patients
J05 Amiodarone appears to have strong fungicidal ability
Industry Advances Emphasis
archive
Preserving residual renal function in diabetics after initiating dialysis (Bargman)
The new peritoneal dialysis K-DOQI guidelines (Burkart) ASN 2002 Renal Week
Peritoneal dialysis adequacy: what is the role of ADEMEX? (Mujais) NKF 2002 Spring Meeting
How should ADEMEX affect PD practice in the United States? (Teitelbaum) NKF 2002 Spring Meeting
Physiology of peritoneal dialysis (Blake) ASN/ISN 2001 Meeting
PD adequacy guidelines: What targets and why? (Burkart) ASN/ISN 2001 Meeting
Role of V in peritoneal dialysis outcomes and adequacy (Lindholm) ASN/ISN 2001 Meeting
Pathophysiology of peritoneal transport (Krediet) CAPD 1999 Meeting
Should PD be the first dialysis therapy of choice for ESRD? (Gokal) CAPD 1999 Sat
Optimizing Pre-ESRD care (Mendelssohn) CAPD 1999 Sat
The shifting paradigm of care for the ESRD patient (Nolph) CAPD 1999 Sat
Multidrug-resistant bacteria in the dialysis unit (Golper) NKF 1998 Spring Clinical Meetings
Psychosocial issues in survival of hemodialysis patients (Kimmel) NKF 1998 Spring Clinical Meetings
Evaluation of patient satisfaction with dialysis (Chapman) CAPD 1998 Symposium
Managed care in dialysis (Hannah) CAPD 1998 Symposium
Quality assessment of a peritoneal dialysis program (Husserl) CAPD 1998 Symposium
Comparison of Economic implications for various PD therapies and payers (Michael) CAPD 1998 Symposium
Results of a CQI (Continuous Quality Improvement) project (Slowik) CAPD 1998 Symposium
Peritoneal dialysis morbidity and mortality: an international perspective (Blake) CAPD 1998 Satellite Symposium
Peritoneal dialysis 2000 (Nolph) CAPD 1998 Satellite Symposium
A brief history of peritoneal dialysis (Oreopoulos) CAPD 1998 Satellite Symposium
Peritonitis and CAPD (Vas) NY Soc Nephrol Lecture Series
Management of pregnancy in CAPD patients (audio only) (Hou) CAPD 1996
DOQI PD GUIDELINES
When to initiate dialysis (1-2)
Measure of PD Dose (3-7)
Details of PD Dose (8-11)
Nutritional Status in PD (12-14)
PD Adequacy (15-18)
Strategies for Dosing PD (19-20)
Clinical Outcome Goals (21-28)
Suitable patients for PD (29-32)
Appendices
References
HDCN Topic Pages
Complications of PD
PD solutions, equipment
PET testing
Physiology
PD Cyclers
Pre-ESRD care
PD procedure: tips
Peritonitis and exit-site infection
PD adequacy
Dialysis outcomes
Quality Assurance
OTHER GUIDELINES
ISPD-Treatment
  PD in kids
  Growth and nutrition in kids
  Lipid disorders
  Catheter exit site
  Peritonitis
  Maximizing clearances
  Peritonitis in kids
ISPD - Quality Assurance
ISPD - Training
STILL MORE LINKS
ISPD
French PD registry
ISPD - History of PD
Advances in PD archive
PD-Adequest Site (Baxter)
Annual Conference on Dialysis
  (Tampa, February 28 - March 2, 2005)
ISPD North Am Chapter Conference
  (Chicago, April 29 - May 1, 2005)

Dr. Christian Verger, M.D.
Director of PD Unit
President of the French PD Registry (http://www.rdplf.org), Service de Dialyse, Hopital Rene Dubos, 95301 Pontoise France